City Therapeutics

Engineering the future of RNAi-based medicine

City Therapeutics is a biotech company in Cambridge, United States, founded in 2024. It has raised $234.5M across 2 rounds, most recently a $99.5M Series B in June 2026.

Employees
51–200
Founded
2024
Business Model
B2B
Website
citytx.com
Total Funding
$234.5M
Last Round
$99.5M Series BJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 12 investors for this company. to use credits for reveals, or explore the API.

About

City Therapeutics is a Cambridge, MA-based clinical-stage biopharmaceutical company founded by RNAi pioneers to engineer next-generation small interfering RNA (siRNA) therapeutics. Its platform advances novel trigger molecules and extrahepatic delivery ligands to expand RNAi reach beyond the liver. Lead programs include CITY-FXI for thromboembolic diseases and CITY-RBP4 for Stargardt disease, backed by over $230 million in financing.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJun 2026
$99.5M

1 more funding event

  • Series A20249 investors

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Frontend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

City Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/city-therapeutics"><img src="https://indexed.vc/api/badge/company/city-therapeutics" alt="City Therapeutics on Indexed.vc" width="260" height="76" /></a>